Buy Side Asset Diligence & Portfolio Strategy
BUSINESS DEVELOPMENT CASE STUDY
Buy Side Asset Diligence & Portfolio Strategy
BUSINESS DEVELOPMENT CASE STUDY
Strategic Overview
Vault Bioventures was hired to conduct a commercial and clinical assessment of a novel, phase III product, with a goal of maximizing portfolio value through a licensing deal.
Following our integrated product assessment, we identified and proposed a go to market strategy that would provide significant incremental value to the client. Our recommendations were adopted by Senior Management which led to a successful licensing deal.
Outcome
Vault Bioventures buy side diligence and subsequent recommendation resulted in a new product acquisition for our client.
The acquisition represented an incremental increase of $3B in peak sales and optimized portfolio profitability.